ResMed, Fisher & Paykel settles global patent disputes

In a joint statement, both medical device makers, ResMed and Fisher & Paykel agreed to end all ongoing infringement cases and said that under the deal neither company will admit any liability or make any payment.

U.S: Medical device maker Fisher & Paykel Healthcare and U.S.-based ResMed on Thursday agreed to settle disputes over patent infringement, bringing to an end a tussle spanning the globe.

The two companies had been at loggerheads in several countries, ranging from the United Kingdom to Australia and the United States, with each alleging that the other infringed its patents.

Also Read: Abbvie settles Humira patent disputes with Novartis unit

Fisher & Paykel, in a separate release, said the settlement will not impact its net profit guidance for the 2019 financial year.

Also Read: Mylan says Allergan misusing tribal sovereignty in patent dispute